PharmEvo Private
PharmEvo (Pvt.) Ltd. is a Karachi-based private Pakistani pharmaceutical company founded in 1999, ranked among the country's top 20, manufacturing branded generics, nutraceuticals, consumer health products, and medical devices across 37 international markets.
- Company typePrivate
- Founded1999
- HeadquartersKarachi, Pakistan
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What PharmEvo Private does
PharmEvo (Pvt.) Ltd. is a Karachi-headquartered, privately held Pakistani pharmaceutical company founded in 1999, operating across four product verticals: branded generic pharmaceuticals, nutraceuticals, consumer health products, and medical devices. Its pharmaceutical portfolio of 86 SKUs spans cardiovascular, anti-diabetic, respiratory, anti-infective, CNS/psychiatry, gastroenterology, orthopedics/pain management, women's health, and oncology (including monoclonal antibodies such as bevacizumab, rituximab, and trastuzumab), supported by a 217,800 sq. ft. GMP-, GLP-, ISO 9001/14001/45001-certified manufacturing facility in Port Qasim with dedicated Cephalosporin, Non-Cephalosporin, and Nutraceutical plants producing multiple dosage forms including tablets, capsules, liquids, sachets, injectables, dry powder suspensions, and dry powder inhalers.
The company ranks among the top 20 pharmaceutical companies in Pakistan and distributes to 37 international markets across South Asia, the Middle East, Central Asia, Caucasus, multiple African regions, Central America, Southeast Asia, and Southeast Europe through affiliate and partner networks. Its go-to-market combines a domestic field sales force targeting physicians and pharmacies, an e-commerce platform (mypharmevo.pk) for direct-to-consumer access, OMRON medical device distribution, and contract manufacturing under international partner brand names. Revenue is generated primarily from one-time branded-generic pharmaceutical sales, with secondary streams from nutraceuticals, consumer health, hardware (medical devices), and professional services (contract manufacturing and pharmacovigilance/MedGuard).
PharmEvo is led by Managing Director M. Haroon Qassim (former chairman of the Pakistan Pharmaceutical Manufacturers Association) and CEO Syed Jamshed Ahmed, with an 18-person leadership team covering commercial, marketing, technical operations, supply chain, finance, medical affairs, and digital functions. The company distinguishes itself through cause-based, ethically marketed disease awareness initiatives (Discovering Diabetes with PES, Discovering Hypertension, Discovering PCOS), HCP engagement platforms (PHARMASSIST, ILE, eDR, Research Forum), and an in-house Learning Management System. No external institutional investors, parent company, or public listing is evidenced in the source material.
PharmEvo Private firmographics
Firmographics- Name
- PharmEvo Private
- Legal name
- PharmEvo (Pvt.) Ltd.
- Website
- https://pharmevo.biz
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- PharmEvo (Pvt.) Ltd. is a Karachi-based private Pakistani pharmaceutical company founded in 1999, ranked among the country's top 20, manufacturing branded generics, nutraceuticals, consumer health products, and medical devices across 37 international markets.
- Ownership category
- akta.pro rank
PharmEvo Private industry classification
Industry- Product category
- Branded Generic Pharmaceuticals
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Specialty Care Pharmaceuticals (HLAIAAAB)
- akta.pro secondary industries
- Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE), Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Infectious Disease & Antimicrobials Pharmaceuticals (HLAIAAAG)
Keywords
Where PharmEvo Private is headquartered
LocationHeadquarters
- HQ city
- Karachi
- HQ country
- Pakistan
- HQ region
- Asia
Offices2 records
Markets served
PharmEvo Private business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Branded Generic Pharmaceuticals: Core pharmaceutical business offering quality branded generic medicines across therapeutic areas including Cardiovascular, Orthopedics, Endocrinology, Respiratory, and Anti-Infective segments. Products sold across 37 international markets.
- Nutraceutical Products: Scientific-based nutraceutical products including vitamins, supplements, and health products manufactured in dedicated modernistic facility.
- Consumer Health Products: Over-the-counter consumer health products including medical devices, wellness products, and health monitoring equipment.
- Medical Devices: Medical devices including blood glucose monitors, thermometers, pulse oximeters, blood pressure monitors, body composition monitors, and nebulizers.
- Contract Manufacturing: Contract manufacturing under International Partner brand name as part of collaborative business models for expansion.
Go-to-market motion2 records
Distribution channels5 records
Marketing channels8 records
PharmEvo Private product offering
Product offeringCore offering
PharmEvo develops, manufactures, and markets a diversified portfolio of 107+ branded generic pharmaceutical products, nutraceuticals, consumer health products, and medical devices across major therapeutic areas including cardiovascular, diabetes, respiratory, anti-infective, CNS, gastroenterology, orthopedics, women's health, and oncology. The company operates three dedicated GMP/GLP-compliant manufacturing facilities and supplies products to healthcare professionals, pharmacies, distributors, and end consumers across Pakistan and 37 international markets.
Product overview
PharmEvo Private is a Pakistani pharmaceutical company operating across four major areas: Pharmaceuticals (86 branded generic products), Nutraceuticals (15 products including vitamins, supplements, and herbal products), Consumer Health (5 OTC products), and Medical Devices (14 products including glucose monitors, blood pressure monitors, and diagnostic devices). The company also operates an e-commerce platform (mypharmevo.pk), maintains a pharmacovigilance program (MedGuard), provides R&D services with GLP and cGMP compliant facilities, and offers a Learning Management System for employee development. The pharmaceutical portfolio spans cardiovascular (X-plended, Xcept, Lowplat, Avsar, Arbi, Tansin, Telsarta, Anplag, Zilero, Sacvin, Ivadin, Zibes, Ramipace, Treatan, Byvas), diabetes care (Inosita, Erli, Galvecta, Dapwiz, EGLARO, Evopride), respiratory (Busonide, Aireez, TioCap, AirCare), anti-infectives (Azliv, EvoFix, Evopravir, Zilfom), CNS/psychiatry (Agoviz, Dipof, Duzalta, Estar, Evo Kalm, Oxivort, Voxamine, Xilica, Klevra, Paridopa), gastroenterology (Fasteso, Redexa, Vanzak, Zoltar), orthopedics/pain management (NISE, Thewril, Gouric, ActNise, Anex-M), women's health (Femova, Ibandro, Onita, Retzole, SheVit), and oncology (Bevec, Rituxim, Traszeptin). The medical device portfolio includes EVOCHECK branded glucose monitors, thermometers, and pulse oximeters, as well as distributed OMRON branded products. Manufacturing operations span three dedicated facilities: Cephalosporin, Non-Cephalosporin, and Nutraceutical, with a global presence in 37 markets.
Differentiator
Problem solved
Functional benefit
Brands
- PHARMASSIST: First ever Toll free Drug and Poison and Pharmacovigilance Centre in Pakistan, providing medication information to healthcare professionals
- ILE (Institute of Leadership Excellence)
- eDR
- Jahan-e-Maseeha
- EvoTalks
- Discovering Diabetes
- Discovering Hypertension
- Discovering PCOS
- Evolve - Wellness Academy
- Darul Kutub
- IGM (Innovation Gateway Meeting)
- MedGuard
Products and services
- Pharmaceuticals (Branded Generics Portfolio)
Quantifiable outcome
- Among top 20 pharmaceutical companies in Pakistan
- +3 more outcomes
Companies that use PharmEvo Private
Customer profileSegments4 records
Ideal customer profiles3 records
PharmEvo Private technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
PharmEvo Private partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered minor and core.
- Various International Drug AuthoritiesminorManufacturing facility has acquired approval from several drug authorities where products are being exported.
- PES (Pakistan Endocrine Society)coreJoint collaboration on Discovering Diabetes initiative for tracking and educating diabetes patients in Pakistan. The initiative aims to educate the Pakistani population for prevention, early detection, and management of diabetes.
- Healthcare Organizations and InstitutionscoreWin-win partnerships with Doctors, Healthcare Organizations and Medical Institutions under eDR program offering diverse value-added services in digital health space.
- International Distribution PartnerscoreNetwork of affiliates and partners across 37 markets including Caucasus, Africa, Central America, Central Asia, Middle East, South Asia, Southeast Asia, Southeast Europe, Southern Africa, and West Africa for branded generics and nutraceuticals distribution.
- Drug Regulatory Authority of Pakistan (DRAP)coreManufacturing facility complies with regulations of DRAP (Drug Regulatory Authority of Pakistan) and has acquired approval from several international drug authorities for exported products.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
PharmEvo Private competitors and assessment
Company assessmentDirect peers
- Getz Pharma: Getz Pharma is one of Pakistan's largest pharmaceutical manufacturers, operating a broad branded-generic and specialty portfolio across cardiovascular, diabetes, anti-infectives, and CNS — directly comparable to PharmEvo in product mix, Pakistani manufacturing footprint, and emerging-market export orientation.
- The Searle Company Limited: Searle is a top-tier Pakistani pharma company with a comparable branded-generic and specialty portfolio spanning multiple therapeutic areas, similar GMP manufacturing infrastructure, and overlap with PharmEvo in diabetes, cardiovascular, and women's health categories.
- Hilton Pharma: Hilton Pharma is a Pakistani pharmaceutical manufacturer with a multi-therapeutic branded-generic portfolio, dedicated manufacturing facilities, and international presence — closely matching PharmEvo in scale, regulatory positioning, and target customer segments.
- Ferozsons Laboratories Limited: Ferozsons is a publicly listed Pakistani pharma company with branded generics and specialty products, manufacturing partnerships with multinationals (e.g., Gilead for hepatitis C), and export operations — comparable to PharmEvo in domestic market positioning and international business model.
Broad incumbents
- Cipla Limited: Cipla is a leading Indian multinational pharmaceutical company with a deep branded-generic and specialty portfolio overlapping PharmEvo's therapeutic focus (respiratory, cardiovascular, anti-infectives, CNS) and significant emerging-market presence — a much larger incumbent competing in many of the same export markets.
- Dr. Reddy's Laboratories: Dr. Reddy's is a major Indian pharma multinational with branded generics, biosimilars, and specialty products across cardiovascular, diabetes, oncology, and CNS — overlapping with PharmEvo's portfolio categories and competing directly in African and Asian emerging markets.
- Sun Pharmaceutical Industries: Sun Pharma is the largest Indian pharma company by revenue with a broad specialty and branded-generic portfolio including cardiology, diabetes, CNS, and respiratory categories that overlap with PharmEvo's core therapeutic areas — a global-scale competitor in emerging markets.
- Aurobindo Pharma: Aurobindo is a major Indian generic and specialty pharmaceutical manufacturer with extensive emerging-market presence in Africa, Asia, and the Middle East — directly comparable to PharmEvo in branded-generic positioning and geographic focus.
Regional players
- Gulf Pharmaceutical Industries (Julphar): Julphar is one of the largest pharmaceutical manufacturers in the Middle East with branded generics across cardio, diabetes, anti-infectives, and consumer health — operating from a similar regional base as PharmEvo and competing in overlapping GCC, African, and South Asian markets.
- Aspen Pharmacare Holdings: Aspen is Africa's largest pharmaceutical manufacturer with branded generics, specialty, and consumer health products across cardiovascular, diabetes, CNS, and anti-infectives — a leading emerging-market pharma peer to PharmEvo with strong presence in African markets where PharmEvo also operates.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
PharmEvo Private social profiles
Digital presencePharmEvo Private compliance and trust
Trust signalCompliance6 records
PharmEvo Private financial estimates
Financial estimateRevenue estimate
Valuation estimate
PharmEvo Private leadership team
Management profileNumber of profiles
Profiles12 records
PharmEvo Private funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PharmEvo Private M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PharmEvo Private
What does PharmEvo Private do?
PharmEvo develops, manufactures, and markets a diversified portfolio of 107+ branded generic pharmaceutical products, nutraceuticals, consumer health products, and medical devices across major therapeutic areas including cardiovascular, diabetes, respiratory, anti-infective, CNS, gastroenterology, orthopedics, women's health, and oncology. The company operates three dedicated GMP/GLP-compliant manufacturing facilities and supplies products to healthcare professionals, pharmacies, distributors, and end consumers across Pakistan and 37 international markets.
Is PharmEvo Private a public or private company?
PharmEvo Private is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was PharmEvo Private founded?
PharmEvo Private was founded in 1999. It employs 1,001 to 5,000 people.
Where is PharmEvo Private based?
PharmEvo Private is headquartered in Karachi, Pakistan, in the Asia region.
How does PharmEvo Private make money?
Five revenue lines are on record. Branded Generic Pharmaceuticals are the primary driver. The others are nutraceutical Products, consumer Health Products, medical Devices and contract Manufacturing.
Who are PharmEvo Private's main competitors?
Direct peers on record are Getz Pharma, The Searle Company Limited, Hilton Pharma and Ferozsons Laboratories Limited. Broad incumbents are Cipla Limited, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries and Aurobindo Pharma. Regional players are Gulf Pharmaceutical Industries (Julphar) and Aspen Pharmacare Holdings.
Does PharmEvo Private have an API?
No public API is recorded for PharmEvo Private.
What industry is PharmEvo Private in?
PharmEvo Private's product category is Branded Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of HLAIAAAE, Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity). Its NAICS code is 3254 and its SIC code is 2834.